{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T13:35:21Z","timestamp":1793367321039,"version":"4.5.0"},"reference-count":28,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2024,1,24]],"date-time":"2024-01-24T00:00:00Z","timestamp":1706054400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,1,24]],"date-time":"2024-01-24T00:00:00Z","timestamp":1706054400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nephrol"],"DOI":"10.1007\/s40620-023-01850-2","type":"journal-article","created":{"date-parts":[[2024,1,24]],"date-time":"2024-01-24T09:36:44Z","timestamp":1706089004000},"page":"911-922","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Acetazolamide for acute kidney injury in patients undergoing high dose methotrexate therapy: a systematic review and meta-analysis"],"prefix":"10.1093","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6846-8369","authenticated-orcid":false,"given":"Hong Hieu","family":"Truong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Swetha","family":"Reddy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariam","family":"Charkviani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nasrin","family":"Nikravangolsefid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob","family":"Ninan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leslie","family":"Hassett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kianoush Banaei","family":"Kashani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Pablo","family":"Domecq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,1,24]]},"reference":[{"issue":"5","key":"1850_CR1","doi-asserted-by":"publisher","first-page":"e217","DOI":"10.1016\/S2352-3026(16)00036-3","volume":"3","author":"AJ Ferreri","year":"2016","unstructured":"Ferreri AJ et al (2016) Chemoimmunotherapy with methotrexate, cytarabine, thiotepa, and rituximab (MATRix regimen) in patients with primary CNS lymphoma: results of the first randomisation of the International Extranodal Lymphoma Study Group-32 (IELSG32) phase 2 trial. Lancet Haematol 3(5):e217\u2013e227","journal-title":"Lancet Haematol"},{"issue":"20","key":"1850_CR2","doi-asserted-by":"publisher","first-page":"5023","DOI":"10.3390\/ijms20205023","volume":"20","author":"Y Bedoui","year":"2019","unstructured":"Bedoui Y et al (2019) Methotrexate an old drug with new tricks. Int J Mol Sci 20(20):5023","journal-title":"Int J Mol Sci"},{"issue":"12","key":"1850_CR3","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1634\/theoncologist.2015-0164","volume":"21","author":"SC Howard","year":"2016","unstructured":"Howard SC et al (2016) Preventing and managing toxicities of high-dose methotrexate. Oncologist 21(12):1471\u20131482","journal-title":"Oncologist"},{"issue":"2","key":"1850_CR4","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1172\/JCI108308","volume":"57","author":"SA Jacobs","year":"1976","unstructured":"Jacobs SA et al (1976) 7-Hydroxymethotrexate as a urinary metabolite in human subjects and rhesus monkeys receiving high dose methotrexate. J Clin Invest 57(2):534\u2013538","journal-title":"J Clin Invest"},{"issue":"2","key":"1850_CR5","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/0304-3835(80)90117-2","volume":"9","author":"J Lankelma","year":"1980","unstructured":"Lankelma J, van der Klein E, Ramaekers F (1980) The role of 7-hydroxymethotrexate during methotrexate anti-cancer therapy. Cancer Lett 9(2):133\u2013142","journal-title":"Cancer Lett"},{"issue":"4","key":"1850_CR6","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.drup.2012.07.002","volume":"15","author":"N Gonen","year":"2012","unstructured":"Gonen N, Assaraf YG (2012) Antifolates in cancer therapy: structure, activity and mechanisms of drug resistance. Drug Resist Updat 15(4):183\u2013210","journal-title":"Drug Resist Updat"},{"issue":"7","key":"1850_CR7","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1002\/phar.2145","volume":"38","author":"CD Flombaum","year":"2018","unstructured":"Flombaum CD et al (2018) Management of patients with acute methotrexate nephrotoxicity with high-dose leucovorin. Pharmacotherapy 38(7):714\u2013724","journal-title":"Pharmacotherapy"},{"issue":"6","key":"1850_CR8","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1016\/j.semnephrol.2010.09.005","volume":"30","author":"MA Perazella","year":"2010","unstructured":"Perazella MA, Moeckel GW (2010) Nephrotoxicity from chemotherapeutic agents: clinical manifestations, pathobiology, and prevention\/therapy. Semin Nephrol 30(6):570\u2013581","journal-title":"Semin Nephrol"},{"key":"1850_CR9","doi-asserted-by":"publisher","first-page":"8065","DOI":"10.2147\/CMAR.S190084","volume":"11","author":"DR Reed","year":"2019","unstructured":"Reed DR et al (2019) A prospective study on urine alkalization with an oral regimen consisting of sodium bicarbonate and acetazolamide in patients receiving high-dose methotrexate. Cancer Manag Res 11:8065\u20138072","journal-title":"Cancer Manag Res"},{"issue":"3","key":"1850_CR10","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1111\/imj.14468","volume":"50","author":"M Ku","year":"2020","unstructured":"Ku M, Bazargan A, Tam C (2020) Addition of low dose acetazolamide as an adjunct in patients undergoing high dose methotrexate is safe and beneficial. Intern Med J 50(3):357\u2013362","journal-title":"Intern Med J"},{"key":"1850_CR11","volume-title":"Statistical methods for rates and proportions","author":"JL Fleiss","year":"2013","unstructured":"Fleiss JL, Levin B, Paik MC (2013) Statistical methods for rates and proportions. John Wiley & Sons"},{"key":"1850_CR12","doi-asserted-by":"publisher","first-page":"159","DOI":"10.2307\/2529310","volume":"33","author":"JR Landis","year":"1977","unstructured":"Landis JR, Koch GG (1977) The measurement of observer agreement for categorical data. Biometrics 33:159\u2013174","journal-title":"Biometrics"},{"issue":"10","key":"1850_CR13","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/j.jclinepi.2009.06.006","volume":"62","author":"A Liberati","year":"2009","unstructured":"Liberati A et al (2009) The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. J Clin Epidemiol 62(10):e1\u2013e34","journal-title":"J Clin Epidemiol"},{"key":"1850_CR14","doi-asserted-by":"publisher","first-page":"i4919","DOI":"10.1136\/bmj.i4919","volume":"355","author":"JA Sterne","year":"2016","unstructured":"Sterne JA et al (2016) ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ 355:i4919","journal-title":"BMJ"},{"key":"1850_CR15","unstructured":"Higgins JP (2011) green S. Cochrane handbook for systematic reviews of interventions version. Version 5.1. 0 [updated March 2011]. https:\/\/www.cochrane-handbook.org\/"},{"issue":"1","key":"1850_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2288-14-135","volume":"14","author":"X Wan","year":"2014","unstructured":"Wan X et al (2014) Estimating the sample mean and standard deviation from the sample size, median, range and\/or interquartile range. BMC Med Res Methodol 14(1):1\u201313","journal-title":"BMC Med Res Methodol"},{"key":"1850_CR17","unstructured":"Kallmes KM, Kallmes KR, Holub K, et al (2021) Nested Knowledge. https:\/\/nested-knowledge.com\/nest\/212. Accessed Sept 2023"},{"issue":"3","key":"1850_CR18","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1007\/s00520-020-05646-z","volume":"29","author":"AB Clemmons","year":"2021","unstructured":"Clemmons AB et al (2021) Assessing the impact of adding acetazolamide to oral or intravenous sodium bicarbonate as compared with intravenous bicarbonate monotherapy as urinary alkalinization in adults receiving high-dose methotrexate. Support Care Cancer 29(3):1527\u20131534","journal-title":"Support Care Cancer"},{"issue":"8","key":"1850_CR19","doi-asserted-by":"publisher","first-page":"1860","DOI":"10.1177\/1078155218821406","volume":"25","author":"AM Roy","year":"2019","unstructured":"Roy AM, Lei M, Lou U (2019) Safety and efficacy of a urine alkalinization protocol developed for high-dose methotrexate patients during intravenous bicarbonate shortage. J Oncol Pharm Pract 25(8):1860\u20131866","journal-title":"J Oncol Pharm Pract"},{"issue":"12","key":"1850_CR20","doi-asserted-by":"publisher","first-page":"2423","DOI":"10.1002\/1097-0142(19880615)61:12<2423::AID-CNCR2820611205>3.0.CO;2-H","volume":"61","author":"A Reggev","year":"1988","unstructured":"Reggev A, Djerassi I (1988) The safety of administration of massive doses of methotrexate (50 g) with equimolar citrovorum factor rescue in adult patients. Cancer 61(12):2423\u20132428","journal-title":"Cancer"},{"issue":"2","key":"1850_CR21","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1007\/BF00689708","volume":"28","author":"J Shamash","year":"1991","unstructured":"Shamash J, Earl H, Souhami R (1991) Acetazolamide for alkalinisation of urine in patients receiving high-dose methotrexate. Cancer Chemother Pharmacol 28(2):150\u2013151","journal-title":"Cancer Chemother Pharmacol"},{"key":"1850_CR22","doi-asserted-by":"publisher","first-page":"S378","DOI":"10.1016\/S2152-2650(21)01862-0","volume":"21","author":"I Motabi","year":"2021","unstructured":"Motabi I et al (2021) ABCL-030: Safety of ambulatory high-dose methotrexate (HDMTX) administration among hematological malignancies patients in a tertiary care center. Clin Lymphoma Myeloma Leuk 21:S378","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"1850_CR23","unstructured":"Sadoff L, Rittmann A (1976) Use of acetazolamide (AC) to alkalinize urine in high dose methotrexate (MTX) therapy in patients with advanced cancer. In: Proceedings of the American association for cancer research. Amer Assoc Cancer Research Public Ledger BLDG, Suite 816, 150 S"},{"key":"1850_CR24","doi-asserted-by":"publisher","first-page":"2309","DOI":"10.1182\/blood-2018-99-112606","volume":"132","author":"DR Reed","year":"2018","unstructured":"Reed DR et al (2018) Oral regimen for urine alkalization in patients receiving high dose methotrexate during a national shortage of intravenous sodium bicarbonate. Blood 132:2309","journal-title":"Blood"},{"key":"1850_CR25","volume-title":"Mayo Clinic Proceedings","author":"ER Fox","year":"2014","unstructured":"Fox ER, Sweet BV, Jensen V (2014) Drug shortages: a complex health care crisis. Mayo Clinic Proceedings. Elsevier"},{"issue":"10","key":"1850_CR26","doi-asserted-by":"publisher","first-page":"2603","DOI":"10.1007\/s00277-021-04593-x","volume":"100","author":"O Ballo","year":"2021","unstructured":"Ballo O et al (2021) Fluid overload is associated with increased 90-day mortality in AML patients undergoing induction chemotherapy. Ann Hematol 100(10):2603\u20132611","journal-title":"Ann Hematol"},{"issue":"1","key":"1850_CR27","doi-asserted-by":"publisher","first-page":"R14","DOI":"10.1186\/cc3970","volume":"10","author":"M Moviat","year":"2006","unstructured":"Moviat M et al (2006) Acetazolamide-mediated decrease in strong ion difference accounts for the correction of metabolic alkalosis in critically ill patients. Crit Care 10(1):R14","journal-title":"Crit Care"},{"issue":"4","key":"1850_CR28","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1016\/0277-5379(88)90320-3","volume":"24","author":"T Abe","year":"1988","unstructured":"Abe T et al (1988) The use of diamox in the sequential methotrexate-5-fluorouracil therapy of advanced gastrointestinal cancer. Eur J Cancer Clin Oncol 24(4):799\u2013800","journal-title":"Eur J Cancer Clin Oncol"}],"container-title":["Journal of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40620-023-01850-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40620-023-01850-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40620-023-01850-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T15:53:57Z","timestamp":1777564437000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/joneph\/article\/37\/4\/911\/8306765"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,24]]},"references-count":28,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2024,5]]}},"alternative-id":["1850"],"URL":"https:\/\/doi.org\/10.1007\/s40620-023-01850-2","relation":{},"ISSN":["1724-6059"],"issn-type":[{"value":"1724-6059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,24]]},"assertion":[{"value":"2 August 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 November 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 January 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}